| |
|
|
|
Keystone Symposia, Steamboat Springs, Colorado
March 27 - April 1, 2007
The metabolic syndrome is a complex entity of metabolic disorders clustering around acquired visceral obesity. These metabolic abnormalities include alterations in glucose homeostasis associated with insulin resistance, atherogenic dyslipidemia, coagulation disturbances and, in many cases, hypertension. Metabolic syndrome patients are at high risk to develop type 2 diabetes and most often die from cardiovascular diseases. Already identified in the early 1950’s and formally presented as syndrome X in the 1980’s, the metabolic syndrome is achieving epidemic proportions in the 21st century, due to global changes in life-style. In this meeting, the most recent conceptual advances in our understanding of the pathogenesis of the metabolic syndrome, its different metabolic components as well as its cardiovascular complications, will be discussed. This meeting aims to integrate approaches from basic and translational science, with an overall goal of understanding 1) how to translate this science into a more optimal lifestyle management and 2) the prospects for therapeutic intervention.
|
|
|
|
|
|
|
|
Organized by:
|
|
Bart Staels, Jean E. Schaffer and Juleen R. Zierath |
|
|
Invited Speakers:
|
|
- E. Abel, University of Utah
- Ronald Evans, The Salk Institute
- Henry Ginsberg, Columbia University College of Physicians and Surgeons
- Christopher Glass, University of California, San Diego
- Göran Hansson, Karolinska University Hospital
- D. Hardie, University of Dundee
- Jay Horton, University of Texas Southwestern Medical Center
- Gökhan Hotamisligil, Harvard University School of Public Health
- Takashi Kadowaki, University of Tokyo
- C. Kahn, Joslin Diabetes Center
- Daniel Kelly, Washington University School of Medicine
- Yannick Le Marchand-Brustel, INSERM
- Peter Libby, Brigham and Women's Hospital
- David Mangelsdorf, University of Texas Southwestern Medical Center
- Elizabeth Nabel, National Institutes of Health
- Mary-Elizabeth Patti, Joslin Diabetes Center
- Gerald Reaven, Stanford University
- Karen Reue, University of California, Los Angeles
- Bernard Scatton, Sanofi-Synthelabo
- Jean Schaffer, Washington University School of Medicine
- Jonathan Seckl, University of Edinburgh School of Molecular and Clinical Medicine
- Clay Semenkovich, Washington University School of Medicine
- Steven Shoelson, Harvard Medical School
- Bruce Spiegelman, Harvard Medical School
- Bart Staels, Institut Pasteur Lille
- Nancy Thornberry, Merck Research Laboratories
- Peter Tontonoz, University of California, Los Angeles
- Fred Turek, Northwestern University
- Hannele Yki-Jarvinen , University of Helsinki
- Juleen Zierath, Karolinska Institutet
|
|
|
|
|
|
|
|
Deadline for Abstracts:
|
|
Nov. 27, 2006
|
|
|
|
|
|
|
|
Registration:
|
|
Please see website
|
|
|
E-mail:
|
|
info@keystonesymposia.org
|
|
|
|
|
|
|
|
|